Commentary Open Access
Volume 2 | Issue 1 | DOI: https://doi.org/10.46439/immunol.2.018
Commentary on Aplasia cutis congenita in monozygotic twins: What should we do further?
Hui-Jun Lai1,3, Ping-Ping Ma2, Mei-Yan Lai1, Hong-Wei Guo1,*
- 1The First Clinical Medical School, Guangdong Medical University, Zhanjiang, Guangdong, China
- 2Department of Dermatology, Affiliated Hospital of Guangdong Medical University, Zhanjiang, Guangdong, China
- 3Department of Dermatology, Guangzhou Red Cross Hospital, Guangzhou, Guangdong, China
Corresponding Author
Hong-Wei Gu, hongweiava@126.com
Received Date: August 03, 2023
Accepted Date: August 14, 2023
Lai HJ, Ma PP, Lai MY, Guo HW. Commentary on Aplasia cutis congenita in monozygotic twins: What should we do further?. J Cell Mol Immunol. 2023;2(1):22-24.
Copyright: © 2023 Lai HJ, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Recommended Articles
Commentary on Aplasia cutis congenita in monozygotic twins: What should we do further?
Aplasia cutis congenita (ACC) is a rare congenital anomaly characterized by a localized or widespread lack of skin at birth. Most information about ACC exists as individual case reports and medium-sized studies. Recently, a study based on the European network of population-based registries for congenital anomalies (EUROCAT) showed that the scalp is the most common site of ACC (96.4%), and 33.8% of cases have related congenital abnormalities. Patau and Adams-Oliver syndromes are the most common among the associated chromosomal anomalies (88.3%) and the associated genetic syndromes (57.7%).
Could in vivo histological and gene expression analysis of aged skin be useful for pointing new paths for cosmetics development?
Skin aging is related to intrinsic or chronological and extrinsic or environmental factors. Oxidative stress, with generation of Reactive Oxygen Species (ROS), occurs during oxidative cell metabolism, mostly on mitochondria, and it is aggravated by chronic exposition to Ultra-Violet (UV)B (short wavelength) and UVA (long wavelength) sun radiations.
Skin necrosis following dobutamine extravasation
Dobutamine is a synthetic catecholamine with activity on both alpha-1 and beta-2 adrenoceptors. It is used intravenously as an inotropic agent for short term treatment of heart failure. Dobutamine side effects involve usually cardiovascular system. Cutaneous side effects such as inflammation in the administration site following accidental extravasation could occur. Skin necrosis from intravenous soft tissue infiltration is a rare but serious complication of intravenous therapy. Herein we report a rare case of a local skin necrosis in dobutamine infusion site.